Kimary Kulig

Business Advisor at Immunai

Kimary Kulig is passionate about the best interest and care of cancer patients. This includes application of artificial intelligence for more accurate diagnosis, minimized tissue-based biomarker testing, predicting response to therapy, and expediting the start of precise therapy.

Kimary’s oncology-focussed pharma career of over 11 years at both Pfizer and Bristol Myers Squibb spanned roles in HealthOutcomes Research, Molecular Epidemiology, and Medical Affairs. Between these roles, Kimary served as Vice President of the Outcomes Research Database at the National Comprehensive Cancer Network(NCCN).

Kimary’s interest in computational and AI approaches to biomarker discovery and companion diagnostic development led herto Google and Verily Life Sciences. There, she formed a multi-disciplinary team to work on digital pathology image analysis algorithms to predict tumor biomarkers and response to treatment. Kimary continues in her goal to bring AI tools to clinical practice in affiliation with PathPresenter Corp. where she serves as Chief Strategy Officer. Kimary is Owner and Principal of Kulig Consulting, LLC, advising companies developing oncology products or services.

Kimary received her PhD from New YorkUniversity’s Institute of Graduate Biomedical Sciences and her MPH fromColumbia University’s Mailman School of Public Health.

Timeline

  • Business Advisor

    Current role